Ceapro Posts Successful Findings in New Study

Ceapro (TSXV:CZO) announced a strong first step on a project of two studies set to investigate a water soluble solid nanodispersion formulation of CoQ10 using its PGX enabling technology.
As quoted in the press release:

This project included two studies, which were conducted at the University of Alberta by Dr. Feral Temelli’s team along with Ceapro researchers.
The primary objective of the first study was to find the optimal technical conditions to combine beta glucan and CoQ10, and to characterize the physical chemistry properties of the resulting newly formed chemical complex. The second study involved the development and testing of a prototype beverage formulation with the new chemical complex developed in the first study.
Positive results were obtained from both studies. The first study resulted in the successful development of a novel water soluble chemical complex (CoQ10-Beta Glucan) obtained from the utilization of Ceapro’s enabling Pressurized Gas eXpanded Technology (“PGX”).
The second study resulted in the successful preparation of an appealing prototype beverage formulation that was determined to be well liked by a trained panel. This conclusion comes from a blinded study involving 91 subjects who were asked to compare two formulations, beta glucan alone (“BG”) versus CoQ10-impregnated beta glucan (“iBG”), based on several attributes such as appearance, flavor, sweetness, aftertaste, bitterness and thickness. No difference was observed between the two formulations, confirming the successful impregnation of the new complex (iBG) and its uniform dispersion in water.

Click here to read the full press release.

Source: www.marketwired.com